CINECA IRIS Institutional Research Information System

MIGLIARDI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.974
AS - Asia 3.335
EU - Europa 2.663
OC - Oceania 107
SA - Sud America 77
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.812
CN - Cina 2.056
IT - Italia 668
GB - Regno Unito 566
DE - Germania 333
JP - Giappone 318
HK - Hong Kong 205
IN - India 199
SG - Singapore 166
FR - Francia 155
CA - Canada 142
IE - Irlanda 116
NL - Olanda 112
ES - Italia 108
SE - Svezia 87
KR - Corea 86
AU - Australia 81
CH - Svizzera 71
PL - Polonia 69
FI - Finlandia 67
TW - Taiwan 66
BE - Belgio 51
BR - Brasile 50
UA - Ucraina 49
TR - Turchia 38
VN - Vietnam 34
AT - Austria 33
IL - Israele 33
PT - Portogallo 27
RU - Federazione Russa 27
NZ - Nuova Zelanda 26
ID - Indonesia 23
TH - Thailandia 23
CZ - Repubblica Ceca 20
DK - Danimarca 20
NO - Norvegia 18
IR - Iran 17
MX - Messico 17
CO - Colombia 16
GR - Grecia 14
HU - Ungheria 12
RO - Romania 12
MY - Malesia 11
MO - Macao, regione amministrativa speciale della Cina 10
PK - Pakistan 9
SA - Arabia Saudita 8
QA - Qatar 7
ZA - Sudafrica 7
LB - Libano 6
SK - Slovacchia (Repubblica Slovacca) 6
AR - Argentina 5
BA - Bosnia-Erzegovina 5
PH - Filippine 5
EC - Ecuador 4
UZ - Uzbekistan 4
EE - Estonia 3
EG - Egitto 3
KH - Cambogia 3
AD - Andorra 2
BG - Bulgaria 2
CL - Cile 2
CU - Cuba 2
CY - Cipro 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
EU - Europa 1
GH - Ghana 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
PR - Porto Rico 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UG - Uganda 1
Totale 10.175
Salva come PNG Salva come JPEG
Città #
Beijing 373
Ann Arbor 332
Shanghai 312
Chandler 236
Fairfield 204
Cambridge 169
Guangzhou 127
Houston 125
Redwood City 122
Seattle 122
Woodbridge 115
Ashburn 113
Singapore 113
Torino 108
Dublin 102
Tokyo 102
Wilmington 92
New York 89
Nanjing 88
Los Angeles 68
San Diego 62
Dearborn 60
London 60
Central 57
Milan 57
Boston 55
Wuhan 54
Chengdu 51
San Francisco 50
Hangzhou 41
Changsha 37
Fremont 37
Taipei 37
Pisa 36
Toronto 36
Turin 35
Chongqing 34
Chicago 33
Central District 32
Naples 32
Nyköping 31
Paris 31
Jacksonville 28
Rome 26
Warsaw 26
Columbus 25
Medford 25
Tianjin 25
Vienna 25
Manchester 24
Princeton 24
Santa Clara 24
Zhengzhou 24
Amsterdam 23
Mumbai 23
Philadelphia 23
Hong Kong 22
Jinan 22
Bengaluru 21
Shenyang 21
Villeurbanne 21
Dong Ket 20
Duncan 20
Brussels 19
Jakarta 19
Munich 19
Ottawa 18
Sydney 18
Berlin 17
Boardman 17
Heidelberg 17
Zurich 17
Barcelona 16
Fuzhou 16
Krakow 16
Lappeenranta 16
San Jose 16
Shenzhen 16
Bethesda 15
Hyderabad 15
Nanchang 15
Toulouse 15
Xian 15
Genoa 14
Helsinki 14
Melbourne 14
Belfast 13
Kolkata 13
Memphis 13
Padova 13
Auckland 12
Chennai 12
Dallas 12
Guiyang 12
Seoul 12
São Paulo 12
Atlanta 11
Brookline 11
Gurgaon 11
Harbin 11
Totale 5.104
Salva come PNG Salva come JPEG
Nome #
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. 5.245
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 723
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 659
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 659
Phosphoproteomics of patient-derived xenographs identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer 353
The genomic landscape of response to EGFR blockade in colorectal cancer 350
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 319
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 318
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 277
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 246
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 243
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells 208
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models 171
Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas 116
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab 97
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene 91
Antitumor activity of Src inhibitor Saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas. 89
Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. 87
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer 30
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 25
Transfer of 4-hydroxynonenal, a inhibitory hemozoin (HZ) product, from HZ or HZ-laden phagocytes to developing human erythroid cells. A model for erythropoiesis inhibition in malaria anemia 9
Totale 10.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.517
article - articoli 0
book - libri 0
conference - conferenze 33
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020486 0 0 0 0 56 100 72 55 69 60 44 30
2020/20211.751 33 102 163 173 156 151 156 137 175 184 141 180
2021/20221.924 185 168 193 209 159 152 168 131 166 122 156 115
2022/20231.454 96 124 87 123 97 191 101 147 152 87 129 120
2023/20242.139 178 157 116 213 169 176 183 200 81 187 243 236
2024/20251.013 201 189 185 218 220 0 0 0 0 0 0 0
Totale 10.315